ライフサイエンスコーパス: provider

1 nd transmitting this to a remote health care provider.

2 ly preventive dental care, regardless of the provider.

3 e never discussed testing with a health care provider.

4 erceived safety and confidence in ultrasound provider.

5 scientist, dental manufacturer, and clinical provider.

6 ual with type 1 diabetes and the health-care provider.

7 osteoarthritis treatment recommendations to providers.

8 tion and immediate management by health care providers.

9 iated with highest payment amounts to fewest providers.

10 ipate in the care plan, and communicate with providers.

11 atients, their families, and the health care providers.

12 bial guidance and were requested by off-site providers.

13 almologist and optometrist laser capsulotomy providers.

14 bers and types of participating patients and providers.

15 ud resources from different commercial cloud providers.

16 deline implementation interventions aimed at providers.

17 ressed less confidence in generic healthcare providers.

18 ee-for-Service (FFS) beneficiaries and their providers.

19 s, household characteristics, and healthcare providers.

20 urrence that is encountered by critical care providers.

21 nurses, intensivists, and advanced practice providers.

22 creates a considerable burden on healthcare providers.

23 rns and the capacities of public and private providers.

24 t the priorities of patients and health-care providers.

25 computational resources from different cloud providers.

26 me medication claims compared with all other providers.

27 E ordering by cardiologists and primary care providers.

28 rate classification systems among healthcare providers.

29 e the intervention is performed and for care providers.

30 ost dangerous place on earth for health-care providers.

31 r eye care providers compared with all other providers (38% vs. 23% by volume, P < 0.001; 79% vs. 56%

32 For 2383 providers (74%), greater than 90% of the anti-VEGF payme

33 of alcohol; * Provide education to oncology providers about the influence of excessive alcohol use a

34 olicy and reimbursement structures that hold providers accountable for outcomes that are dependent on

35 Eye care providers accounted for $2.4 billion in total Medicare p

36 y the Medicare Improvements for Patients and Providers Act of 2008, which directed the Centers for Me

37 rom direct observations of care to calculate providers' adherence to evidence-based care guidelines.

38 Medicare Provider Analysis and Review data contain robust informa

39 2009, and December 1, 2009, in the Medicare Provider Analysis and Review database.

40 The Medicare Provider Analysis and Review procedure codes for mechani

41 ICU or coronary care unit charge in Medicare Provider Analysis and Review.

42 et, 80.1% were matched with data in Medicare Provider Analysis and Review.

43 Using Medicare Provider and Analysis Review files, we studied patients

44 acotherapy with buprenorphine or naltrexone, provider and community education, coordination and integ

45 ibing in paediatric outpatients by targeting providers and caregivers in primary care hospitals in ru

46 tions on antimicrobial stewardship targeting providers and caregivers substantially reduced prescribi

47 suboptimal quality of care and burnout among providers and contribute to inefficient health resource

48 l working group, comprised of 26 health care providers and patient advocates, to develop a standard s

49 itive results were not confirmed; therefore, providers and patients must understand that IgM results

50 The intervention involved education of providers and patients, with regular monitoring and feed

51 s Hospital Consumer Assessment of Healthcare Providers and Services (HCAHPS).Hospitals were rated for

52 Interactions between providers and standardized patients were assessed agains

53 ention that established a network of private providers and strengthened the skills of both public and

54 s from the Consumer Assessment of Healthcare Providers and Systems were combined into a composite ind

55 s, and types of impairment can better inform providers and the healthcare system.

56 t demonstration of competence by health care providers and the systems in which they work.

57 ion adherence among a sample of primary care providers and their black and white hypertensive patient

58 We investigated patient, provider, and health system factors associated with rece

59 randomized trial with assignment to patient, provider, and patient-provider interventions or usual ca

60 ith HCC cared for at VA centers, geographic, provider, and system differences in receipt of active HC

61 vailable empirical data on abortion methods, providers, and settings, and factors affecting safety as

62 suboptimal surveillance rests with patients, providers, and the overall health care system; several m

63 ility of research that policymakers, service providers, and the public can use to make decisions will

64 tween general nephrology practices, dialysis providers, and transplant centers to develop care coordi

65 identified multivariable baseline patient-, provider-, and facility-level factors associated with ad

66 Community members; service providers; and district, provincial, and national offici

67 Health care providers are not providing patient-centered care by app

68 Most eye care providers assess patients' smoking status and educate pa

69 To investigate practice patterns of eye care providers at academic medical centers in the United Stat

70 infection control practices, and health-care provider awareness.

71 To examine whether patient-based, provider-based, and patient-provider interventions impro

72 treach, electronic medical record-integrated provider best practice alert [BPA], and direct patient s

73 ronments so NPs can practice as primary care providers can be an effective strategy to increase the p

74 Jordan Greenbaum discusses ways healthcare providers can identify children trafficked for sex to pr

75 adds further evidence that advanced practice providers can render safe and effective ICU care.

76 ferences, blinding (patient), blinding (care provider [care provider is a specific quality metric use

77 aim to contextualise the recommendation for providers caring for patients with IPF.

78 014 from the Guttmacher Institute's Abortion Provider Census.

79 ltiple sectors, including public and private providers, chemists, and non-allopathic practitioners.

80 HIV testing delivered by community HIV-care providers (CHiPs) who also support linkage to care, ART

81 Consumer-reported patient-provider communication (PPC) assessed by Consumer Assess

82 h documenting an association between patient-provider communication and medication adherence, there a

83 tient complexity/acuity," along with patient-provider communication issues ("paucity of advance care

84 study was to evaluate the impact of patient-provider communication on medication adherence among a s

85 Three categories of patient-provider communication predicted poor medication adheren

86 d therefore, also by total cost for eye care providers compared with all other providers (38% vs. 23%

87 orted help-seeking from clinical and welfare providers comparing those receiving tailored advice and

88 ns of care, pain management, patient safety, provider competence), communication (n = 3; information

89 computing market, which have witnessed more providers competing in terms of products and prices.

90 ce of symptom burden, the barriers to parent-provider concordance with regards to prognosis, as well

91 40 810 adult travelers were included; providers considered 6612 (16%) to be eligible for MMR v

92 Most providers consulted for care were general physicians.

93 he health of the either the mother or fetus, providers continue to recommend the women with HIV avoid

94 or beneficiaries attributed to local non-ACO providers (control group).

95 The mean health service (provider) cost per study participant was $168.79 (149.16

96 Medicare and Medicaid Services will evaluate provider costs through episodes of care, which are curre

97 For the SIA, 42% of providers created an SIA high-risk villages list, and >5

98 se of traveler refusal, 966 (28%) because of provider decision, and 822 (24%) because of health syste

99 ral regurgitation, respectively, with 20% of providers deemed overutilizers of TTEs and 25% underutil

100 Primary care provider-delivered preventive dental care did not signif

101 tices to other health care organizations and providers delivering HCV care, contributing to a concert

102 In some settings, NPs serve as primary care providers delivering ongoing continuous care to their pa

103 To account for this, health care providers diagnose obesity using BMI percentiles for eac

104 as defined as caretaker report of healthcare provider-diagnosed allergy to the above foods prior to a

105 more by sociodemographic factors and type of provider diagnosing the enrollee than by medical indicat

106 nase and endomysium or on both a health care provider diagnosis and adherence to a gluten-free diet.

107 Participants with a health care provider diagnosis of celiac disease had a lower mean le

108 c recommendations, suggest opportunities for provider education or tailored guidance.

109 Patient-provider encounters were audiotaped at baseline and code

110 licensed US physicians (per National Plan & Provider Enumeration System) linked to 2015 Open Payment

111 ion," "mismatches between patient/family and provider expectations," and "timeliness of end-of-life c

112 utilized, modifiable adolescent, parent, and provider factors associated with banking outcomes were i

113 ent for patient variables, likely because of provider factors.

114 on ICU capacity and its perceived impact on providers, families, and patient care were explored.

115 pharmacist notification and prospective AMS provider feedback.

116 each of people with health needs than health providers, filled the administration gaps left in their

117 testing) (override group) and those in whom providers followed Wells criteria (CT pulmonary angiogra

118 for 20 immunoassays are valuable to testing providers for interpreting negative HIV test results obt

119 ing surveys were filled out by the referring providers for patients with biochemical recurrence who w

120 ecent immigrants acted as social-information providers, foragers responded to them less than they did

121 care plans to patients and their health care providers from December 2012 to July 2014.

122 for the cost-effectiveness of changing care providers from doctors to nurses and as the majority of

123 ner stage >/= 3), their parents, and medical providers from eight leading pediatric oncology centers

124 e brand medications by volume than any other provider group.

125 about patients' preferences regarding which providers handle their care needs after primary cancer t

126 Patient preferences regarding which provider handles the following care needs after treatmen

127 is occurring at a time when the need for ID providers has never been greater and the excitement and

128 Studies report that healthcare providers have adequate knowledge of the etiology of dia

129 f this study were to (1) describe healthcare provider (HCP) knowledge and practices, (2) explore HCP

130 ecommend regular follow-up with a healthcare provider (HCP).

131 communication between hospital and community providers), holistic care (n = 4; patient hygiene, kindn

132 We linked this information to National Provider Identifier data, identified a set of distinct p

133 creased SGM cultural competency training for providers; improvement of quality-of-care metrics that i

134 ts underwent radical prostatectomy at an NHS provider in England.

135 lit Health Services, the largest health care provider in Israel.

136 extracted from the largest health insurance provider in the Netherlands.

137 udy included 92 hypertensive patients and 27 providers in 3 safety-net primary care practices in New

138 hina's rural health system, interacting with providers in 46 village clinics, 207 township health cen

139 Using a national registry, care providers in a specialized health care network for a rar

140 rers offer plans covering a narrow subset of providers in an attempt to lower premiums and compete fo

141 patients and caregivers, and for health-care providers in Europe.

142 n tools are seen as promising second opinion providers in reducing such errors.

143 d >/=16 years) registered with primary carer providers in the community (mean 455 508 inhabitants) or

144 cational outreach visits (1 of 1 review) and provider incentives (1 of 1 review) were also generally

145 2 reviews), reminders (3 of 4 reviews), and provider incentives (1 of 1 review) were generally effec

146 Provider incentives showed mixed effectiveness for impro

147 Reminders and provider incentives showed mixed effectiveness, or were

148 each visits, (3) audit and feedback, and (4) provider incentives.

149 ble factors, including having a regular care provider, increasing access to care, enrollment in healt

150 To explore evidence for provider-induced demand in the management of carotid art

151 r support programs are needed in addition to provider-initiated and opt-out HIV testing in adolescent

152 Provider-initiated testing and counselling (PITC) in hea

153 edication adherence are greater when patient-provider interactions are low in patient centeredness an

154 dies from the qualitative data on the health provider interface that can be used to improve success o

155 o a previous study of a combined patient and provider intervention for osteoarthritis in a Department

156 The provider intervention involved electronic delivery of pa

157 r patient-based, provider-based, and patient-provider interventions improve osteoarthritis outcomes.

158 assignment to patient, provider, and patient-provider interventions or usual care.

159 ing (patient), blinding (care provider [care provider is a specific quality metric used by the CBN Ri

160 The total cost attributable to eye care providers is driven by glaucoma medications, accounting

161 Successful working with primary care providers is essential to scaling-up AIT provision in Eu

162 positive changes were measured in healthcare provider knowledge of adverse events following immunizat

163 pen narratives, 3 were related to healthcare providers-lack of timely attention, poor skills (knowled

164 Provider-level and facility factors were also associated

165 s a function of procedure year, patient- and provider-level factors, and facility effects.

166 -up appointments, and patient navigators), 5 provider-level interventions (reminders or performance d

167 Provider lists for these plans reduced into 295 unique n

168 th presumptive TB, which may not reflect how providers manage repeat patients or more complicated TB

169 Nongeneticist providers may be able to manage WGS results appropriatel

170 Providers may refer family and friend caregivers of pati

171 To quantify costs of eye care providers' Medicare Part D prescribing patterns for opht

172 ory bowel disease is complicated by multiple providers, misinformation, and a disease entity that, pa

173 Providers monitored immunosuppression levels; both patie

174 PrEP providers need to be aware that infection can occur desp

175 Conclusion Narrower provider networks are more likely to exclude oncologists

176 Methods We examined provider networks offered on the 2014 individual health

177 dentifier data, identified a set of distinct provider networks, and assessed the rates of inclusion o

178 ticular affiliations are in or out of narrow provider networks.

179 re less dependent on medical congresses as a provider of knowledge and education.

180 Veterans Health Administration, the largest provider of liver-related health care in the United Stat

181 caffolding filament, signaling platform, and provider of passive tension and elasticity in myocytes.

182 ld offer ways for consumers to learn whether providers of cancer care with particular affiliations ar

183 Wetlands are important providers of ecosystem services and key regulators of cl

184 Ants, important providers of ecosystem services such as biological contr

185 arth's dominant land cover and are important providers of ecosystem services.

186 evidence and provide guidance to health care providers on the initial pharmacologic treatment of seas

187 .45; CI, 1.28-1.64), and having a usual care provider (OR = 1.50; CI, 1.25-1.80).

188 ciation between participation in the MSSP by provider organizations and medication use or adherence a

189 igh overhead cost environment of health care provider organizations, stakeholders must understand the

190 intenance organizations to 49% for preferred provider organizations; P = .04) but not by metal level.

191 hanges attempt to expand veterans' access to providers outside the Department of Veterans Affairs (VA

192 determine the frequency of, and yield after, provider overrides of evidence-based clinical decision s

193 of an acute PE finding were 51.3% lower when providers overrode alerts than when they followed CDS gu

194 aminations) was compared in patients in whom providers overrode CDS alerts (by performing CT pulmonar

195 ow networks may limit access to high-quality providers, particularly those caring for patients with c

196 agement paradigms include enhancement of the provider-patient relationship, longitudinal studies to i

197 s and barriers, and sound practices to guide providers, patients, and families.

198 reatment content is critical for health care providers, payers, and policy makers, as well as mechani

199 s-oncology-directed care versus primary care provider (PCP)-directed care-were assessed by using mult

200 2 [CI, 1.09-5.76]; P=0.03), and primary care provider (PCP; OR, 2.00 [CI, 1.08-3.75]; P=0.03).

201 been described, which focus on primary care providers (PCPs) as receiving cancer survivors who are t

202 15, and December 31, 2015, by 84 health care providers (physicians, nurse practitioners, physician as

203 ble new information for governments and care providers planning the resources and funding required fo

204 e proportion of outcome variation because of provider practice.

205 Evidence-based strategies to improve provider practices and patient adherence across health s

206 Using health-care provider preference as an IV method, we propose a 2-step

207 First, the provider preference IV value is estimated by performing

208 Eye care providers prescribe more brand medications by volume tha

209 Predictors of noninitiation included lack of provider recommendation (OR, 10.8; 95% CI, 6.5 to 18.0;

210 le injections was associated with a positive provider recommendation to the caregiver.

211 Data on provider referrals were not collected.

212 SPSTF) makes recommendations to primary care providers regarding preventive services for asymptomatic

213 sources (eg, WHO reports and health-service-provider registeries) reporting on yellow fever vaccinat

214 ach with subthemes): patient/family related, provider related, resource related, and health system re

215 Provider-related factor subthemes were nursing workforce

216 e and adherence, and to optimize the patient-provider relationship.

217 forecasting and procurement, and addressing provider reluctance to use BPG.

218 y and efficiency of this procedure, yet some providers remain reluctant to perform it.

219 te evidence supported patient navigators and provider reminders or performance data.

220 Patient navigators and giving providers reminders or performance data may help improve

221 Twenty percent of providers reported cancelling >/=1 RI sessions during th

222 ity and Optison after spontaneous healthcare provider reports of 4 patient deaths and approximately 1

223 Patients, providers, researchers, and outcome assessors were blind

224 tivities and materials to improve healthcare providers' RI knowledge and practices throughout Nepal.

225 e suggested a need for greater clarity about provider roles in team-based cancer care; however, littl

226 ent demographic factors with preferences for provider roles-oncology-directed care versus primary car

227 riteria for MMR vaccination according to the provider's assessment, but fewer than half of these trav

228 f peanut-containing foods in the health care provider's office or at home.

229 uded midlevel surgical residents, anesthesia providers, scrub nurses, and circulating nurses.

230 months, and for selected patients and their providers self-measured BP may be a helpful adjunct to r

231 Advanced life support providers should be trained to use a manual defibrillati

232 with substantial long-term survival benefit; providers should consider this benefit when counseling p

233 reduce prescription expenditures by eye care providers should focus on increasing the use of generic

234 Healthcare providers should monitor oxygen saturation and requireme

235 RT-PCR is the preferred testing method; providers should not rely on IgM testing alone.

236 ions that identifier practitioners (database providers) should take in the design, provision and reus

237 Data on provider-side costs were also collected and analysed.

238 s about Antiretroviral Therapy', 'Healthcare providers', 'Significant others', 'Motherhood and fulfil

239 or differences in patient populations across providers so that differences in outcomes are truly attr

240 systematic errors would likely occur unless providers standardize their coding.

241 f the Federal Joint Committee, a major payer-provider structure given the task of defining uniform ru

242 e outcome can be influenced substantially by providers (that is, a strong process-outcome link exists

243 ursement for these tests by health insurance providers, their widespread clinical implementation, and

244 s to stewardship has focused on primary care providers, there is a significant opportunity for surgeo

245 o screen remote areas with a shortage of ROP providers, thereby reducing the burden of disease.

246 hat reporting 30-day mortality may influence providers' timing of treatment withdrawal.

247 oncologist but also want their primary care provider to have a role.

248 of care advance the imperative for radiology providers to articulate their value.

249 It therefore is important for health care providers to carefully consider prolonged PPI use by pat

250 Outcomes (Project ECHO) enables primary care providers to deliver best-practice care for complex cond

251 re has sponsored pilot projects to encourage providers to develop care coordination and population he

252 se results highlight the need for healthcare providers to ensure guidelines are followed when perform

253 y expand the availability of community-based providers to escalate HCV therapy, bridging existing gap

254 We engaged interprofessional healthcare providers to explore their perceptions of the sources, i

255 participants, study investigators, and care providers to group allocation was not possible.

256 consent, can adhere to follow-up, and alert providers to hepatitis symptoms.

257 ommendations It is important for health care providers to initiate the discussion regarding the poten

258 ional biologists from bioinformatics service providers to leaders of cutting-edge programs highlights

259 he Epic hospital information system, allowed providers to override the intervention by calling the la

260 Critical care nurses, are the primary care providers to patients and families at the end-of-life in

261 e advisory" (BPA) that prompted primary care providers to perform HCV screening for patients seen in

262 second-line regimens and shifting treatment providers to professional hospitals should be considered

263 Efforts should be made by prenatal care providers to provide Tdap vaccine to pregnant women duri

264 rs randomized cardiologists and primary care providers to receive either intervention or control (no

265 vides an excellent opportunity for radiology providers to take a leading role within the health care

266 rative that patient education and healthcare provider training on ART adherence be enhanced and accou

267 pulsory admission occurred at LSOA level and provider trust levels, respectively, after adjusting for

268 atients, covering 64 National Health Service provider trusts (93%) and 31 865 census lower super outp

269 s were excluded, including three independent provider trusts that lacked spatial identification codes

270 Data from eight provider trusts were excluded, including three independe

271 ine characteristics of patients seen by each provider type were similar.

272 f treatment were calculated for patient age, provider type, and county characteristics (rural vs metr

273 fter adjusting for patient age and encounter provider type.

274 All providers underwent an identical 3-hour training session

275 (1:1) by an interactive response technology provider using a validated system to receive either oral

276 ork, with researchers, investors, technology providers, utilities, regulators, and other stakeholders

277 ese claims were identified from the Medicare Provider Utilization and Payment Data from the Centers f

278 Observed trends in high-cost imaging use and provider variation were compared with the same measures

279 ent capacity through the use of nonphysician providers, video telehealth, and electronic technologies

280 d from 7.6% for patients with a primary care provider visit in the 6 months prior to BPA to 72% over

281 times between the beneficiary and the laser provider were calculated by using Google Maps distance a

282 dership support and relationships with other providers were compared across groups using chi-squared

283 Advanced practice providers were present in most of the ICUs (37/43; 86.0%

284 Approximately half of providers were white (56%), 67% women, and have been in

285 ions, interviews with the primary healthcare provider who administered vaccines at each facility, and

286 come measures include proportion of eye care providers who assess patients' smoking status, educate p

287 d best evidence-based guidance to healthcare providers who diagnose and manage Kawasaki disease, but

288 on and training for laypeople and healthcare providers who perform cardiopulmonary resuscitation.

289 gagement of affected communities and medical providers who serve those communities, and increased pub

290 As of the beginning of 2017, providers will be evaluated on quality and in later year

291 Providing the health care provider with tools to diagnose and manage psychological

292 nt and recommendations to assist health care providers with appropriate management of patients with b

293 f GC care were higher in patients treated by providers with greater specialization in arrhythmias (60

294 aims were useful to identify populations and providers with high antibiotic use.

295 te the NP role in care delivery-primary care providers with the own patient panels or delivering epis

296 incidence of the NPs serving as primary care providers with their own patient panel doubled.

297 About 45% of NPs served as primary care providers with their own patient panel.

298 ng process for both young adults and service providers, with complex transition interventions interac

299 thered electronically from multidisciplinary providers within outpatient clinics throughout the Unite

300 ent schemes can facilitate ecosystem service providers without augmenting herbivore (pest) population